|
Periodontal Indices in Patients with Rheumatoid Arthritis Undergoing Immunosuppressive Therapy
|
Ilnaz Frahoudi1    , Afsaneh Enteshari-Moghaddam * 2, Zakiyeh Movahedzadeh3 |
1- Assistant Professor, Department of Periodontics, Faculty of Dentistry, Ardabil University of Medical Sciences, Ardabil, Iran.
2- Associate Professor of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran. , afsanehenteshari2020@gmail.com
3- General Physician, Fcaulty of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran. |
|
|
Abstract: (1412 Views) |
Background and Objective: Periodontitis and rheumatoid arthritis are two chronic inflammatory diseases that are interrelated. Given the similarities between these conditions, the medications used by patients with rheumatoid arthritis (RA) may affect their periodontal indices. This study aimed to evaluate the periodontal index status in patients with RA undergoing immunosuppressive therapy.
Methods: This comparative cross-sectional study was conducted on 68 patients with RA in three treatment groups (20 on monotherapy, 24 on dual therapy, and 24 on triple treatment) and 20 healthy individuals with a plaque index (PI) below 35% in Ardabil, Iran during the second half of 2021. The monotherapy group included methotrexate or hydroxychloroquine; the dual therapy group included combinations of methotrexate with hydroxychloroquine, adalimumab, or infliximab; and the triple therapy group included combinations of methotrexate and hydroxychloroquine with adalimumab, etanercept, sulfasalazine, or leflunomide. Periodontal indices, including Plaque Index (PI), Clinical Attachment Loss (CAL), Gingival Index (GI), and Bleeding on Probing (BOP), were assessed.
Results: There were no statistically significant differences in periodontal indices among the three treatment groups (monotherapy, dual therapy, and triple therapy). The mean BOP index in the control group was significantly higher compared to the three medication groups (P<0.05). There were no statistically significant differences in the mean CAL and GI indices between the control group and the medication groups. The median PI in the control group was 29.6, and in the dual therapy group, it was 42.3, which was statistically significant (P<0.05).
Conclusion: The use of immunosuppressive drugs did not have a significant effect on the periodontal indices of patients with rheumatoid arthritis. |
|
Keywords: Periodontal Index [MeSH], Rheumatoid Arthritis [MeSH], Antirheumatic Agents [MeSH], Immunosuppression Therapy [MeSH]
Article ID: Vol26-19 |
|
|
Full-Text [PDF 633 kb]
(3185 Downloads)
| | Abstract (HTML) (120 Views)
|
|
Type of Study: Original Articles |
Subject:
Rheumatology
|
|
|
|
|
|
|
| References |
1. Chou YY, Lai KL, Chen DY, Lin CH, Chen HH. Rheumatoid Arthritis Risk Associated with Periodontitis Exposure: A Nationwide, Population-Based Cohort Study. PLoS One. 2015 Oct;10(10):e0139693. doi: 10.1371/journal.pone.0139693. [ DOI] [ PubMed] 2. de Oliveira Ferreira R, de Brito Silva R, Magno MB, Carvalho Almeida APCPS, Fagundes NCF, Maia LC, et al. Does periodontitis represent a risk factor for rheumatoid arthritis? A systematic review and meta-analysis. Ther Adv Musculoskelet Dis. 2019 Jul;11:1759720X19858514. doi: 10.1177/1759720X19858514. [ DOI] [ PubMed] 3. Tang Q, Fu H, Qin B, Hu Z, Liu Y, Liang Y, et al. A Possible Link Between Rheumatoid Arthritis and Periodontitis: A Systematic Review and Meta-analysis. Int J Periodontics Restorative Dent. 2017 Jan/Feb;37(1):79-86. doi: 10.11607/prd.2656. [ DOI] [ PubMed] 4. Jeffery RC. Clinical Features of Rheumatoid Arthritis. Medicine. 2014; 42(5): 231-36. doi: 10.1016/j.mpmed.2014.02.011. [ Link] [ DOI] 5. Ziebolz D, Rupprecht A, Schmickler J, Bothmann L, Krämer J, Patschan D, et al. Association of different immunosuppressive medications with periodontal condition in patients with rheumatoid arthritis: Results from a cross-sectional study. J Periodontol. 2018 Nov;89(11):1310-17. doi: 10.1002/JPER.17-0616. [ DOI] [ PubMed] 6. Schmickler J, Rupprecht A, Patschan S, Patschan D, Müller GA, Haak R, et al. Cross-Sectional Evaluation of Periodontal Status and Microbiologic and Rheumatoid Parameters in a Large Cohort of Patients With Rheumatoid Arthritis. J Periodontol. 2017 Apr;88(4):368-79. doi: 10.1902/jop.2016.160355. [ DOI] [ PubMed] 7. Eriksson K, Nise L, Kats A, Luttropp E, Catrina AI, Askling J, et al. Prevalence of Periodontitis in Patients with Established Rheumatoid Arthritis: A Swedish Population Based Case-Control Study. PLoS One. 2016 May;11(5):e0155956. doi: 10.1371/journal.pone.0155956. [ DOI] [ PubMed] 8. Pischon N, Pischon T, Kröger J, Gülmez E, Kleber BM, Bernimoulin JP, et al. Association among rheumatoid arthritis, oral hygiene, and periodontitis. J Periodontol. 2008 Jun;79(6):979-86. doi: 10.1902/jop.2008.070501. [ DOI] [ PubMed] 9. Bello-Gualtero JM, Lafaurie GI, Hoyos LX, Castillo DM, De-Avila J, Munevar JC, et al. Periodontal Disease in Individuals With a Genetic Risk of Developing Arthritis and Early Rheumatoid Arthritis: A Cross-Sectional Study. J Periodontol. 2016 Apr;87(4):346-56. doi: 10.1902/jop.2015.150455. [ DOI] [ PubMed] 10. Dissick A, Redman RS, Jones M, Rangan BV, Reimold A, Griffiths GR, et al. Association of periodontitis with rheumatoid arthritis: a pilot study. J Periodontol. 2010 Feb;81(2):223-30. doi: 10.1902/jop.2009.090309. [ DOI] [ PubMed] 11. Romero-Sanchez C, Rodríguez C, Santos-Moreno P, Mesa AM, Lafaurie GI, Giraldo-Q S, et al. Is the Treatment with Biological or Non-biological DMARDS a Modifier of Periodontal Condition in Patients with Rheumatoid Arthritis? Curr Rheumatol Rev. 2017;13(2):139-51. doi: 10.2174/1573397113666170407161520. [ DOI] [ PubMed] 12. Jung GU, Han JY, Hwang KG, Park CJ, Stathopoulou PG, Fiorellini JP. Effects of Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Response to Periodontal Treatment in Patients with Rheumatoid Arthritis. Biomed Res Int. 2018 Aug;2018:1465402. doi: 10.1155/2018/1465402. [ DOI] [ PubMed] 13. Kobayashi T, Okada M, Ito S, Kobayashi D, Ishida K, Kojima A, et al. Assessment of interleukin-6 receptor inhibition therapy on periodontal condition in patients with rheumatoid arthritis and chronic periodontitis. J Periodontol. 2014 Jan;85(1):57-67. doi: 10.1902/jop.2013.120696. [ DOI] [ PubMed] 14. Kobayashi T, Yokoyama T, Ito S, Kobayashi D, Yamagata A, Okada M, et al. Periodontal and serum protein profiles in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitor adalimumab. J Periodontol. 2014 Nov;85(11):1480-88. doi: 10.1902/jop.2014.140194. [ DOI] [ PubMed] 15. Esfahanian, V., Mahabadi, M., Soleimani, M., Dehdarian, A. [Association between Keratinized Tissue width and Periodental Indices around Implant Supported Fixed Prosthesis]. Journal of Mashhad Dental School. 2016;40(1):1-8. doi: 10.22038/jmds.2016.6338. [Article in Persian] [ Link] [ DOI] 16. Abdelsalam SK, Hashim NT, Elsalamabi EM, Gismalla BG. Periodontal status of rheumatoid arthritis patients in khartoum state. BMC Res Notes. 2011 Oct;4:460. doi: 10.1186/1756-0500-4-460. [ DOI] [ PubMed] 17. Äyräväinen L, Heikkinen AM, Kuuliala A, Ahola K, Koivuniemi R, Moilanen E, et al. Anti-rheumatic medication and salivary MMP-8, a biomarker for periodontal disease. Oral Dis. 2018 Nov;24(8):1562-71. doi: 10.1111/odi.12930. [ DOI] [ PubMed] 18. Kordtabar S, Aghaie M, Fakhari E, Vakili MA. Periodontal Condition in Patients with Rheumatoid Arthritis: Effect of Anti-rheumatic Drugs. J Dent (Shiraz). 2019 Sep;20(3):190-94. doi: 10.30476/DENTJODS.2019.44914. [ DOI] [ PubMed] 19. Ishi Ede P, Bertolo MB, Rossa C Jr, Kirkwood KL, Onofre MA. Periodontal condition in patients with rheumatoid arthritis. Braz Oral Res. 2008 Jan-Mar;22(1):72-7. doi: 10.1590/s1806-83242008000100013. [ DOI] [ PubMed] 20. Mercado FB, Marshall RI, Klestov AC, Bartold PM. Relationship between rheumatoid arthritis and periodontitis. J Periodontol. 2001 Jun;72(6):779-87. doi: 10.1902/jop.2001.72.6.779. [ DOI] [ PubMed] 21. Mayer Y, Balbir-Gurman A, Machtei EE. Anti-tumor necrosis factor-alpha therapy and periodontal parameters in patients with rheumatoid arthritis. J Periodontol. 2009 Sep;80(9):1414-20. doi: 10.1902/jop.2009.090015. [ DOI] [ PubMed] 22. Mayer Y, Elimelech R, Balbir-Gurman A, Braun-Moscovici Y, Machtei EE. Periodontal condition of patients with autoimmune diseases and the effect of anti-tumor necrosis factor-α therapy. J Periodontol. 2013 Feb;84(2):136-42. doi: 10.1902/jop.2012.120009. [ DOI] [ PubMed] 23. Ortiz P, Bissada NF, Palomo L, Han YW, Al-Zahrani MS, Panneerselvam A, et al. Periodontal therapy reduces the severity of active rheumatoid arthritis in patients treated with or without tumor necrosis factor inhibitors. J Periodontol. 2009 Apr;80(4):535-40. doi: 10.1902/jop.2009.080447. [ DOI] [ PubMed] 24. Taheri M, Saghafi M, Najafi M, Radvar M, Marjani S, Javanbakht A, et al. [Investigation of Periodontal Conditions in Patients with Rheumatoid Arthritis]. Journal of Mashhad Dental School. 2011; 35(4): 283-88. doi: 10.22038/jmds.2011.948. [ Link] [ DOI] 25. de Pablo P, Dietrich T, McAlindon TE. Association of periodontal disease and tooth loss with rheumatoid arthritis in the US population. J Rheumatol. 2008 Jan;35(1):70-6. [ PubMed] |
|
| Send email to the article author |
|
|
|
|
